UNSPSC 51242103: Naphazoline/phenylephrine/pyrilamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class NT900. This VA Drug Class (NT900) classifies this compound as belonging to the group NASAL AND THROAT, TOPICAL, OTHER.

UNSPSC 51242103 Naphazoline/phenylephrine/pyrilamine (Commodity) describes a specific combination decongestant and antihistamine ophthalmic product that state and local governments procure for public health programs, correctional facilities, emergency response services, and school health clinics. The product combines a nasal decongestant (naphazoline), a sympathomimetic agent (phenylephrine), and an antihistamine (pyrilamine) in formulation for treatment of allergic rhinitis and related upper-respiratory conditions. State and local procurement under this code serves institutional and population-health use cases rather than consumer retail distribution.

The source provided contains no recent state or local contract opportunities under this code. Without posted solicitations, RFQs, or IFBs to reference, no issuing-body mix, geographic concentration, or representative recent procurements can be identified from current market activity.